Clinical Trial Update: A Safety Study in Participants With Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 safety study in adults with major depressive disorder has completed and posted results. Sponsored by Eli Lilly and Company, the trial's safety results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2018-04-17